 |
|
Antiretroviral Therapy and the Prevalence and Incidence of Diabetes
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In the study by Brown et al,1 the authors did not mention several limitations that might have an important impact on the interpretation of the results. First, the study only included men, who were mostly white (approximately 86%). Therefore, the results cannot be extrapolated to women and other ethnic groups. Second, the family history of diabetes was not ascertained in the study participants, and this could have confounded the magnitude of differences in prevalence and incidence of diabetes between the 2 study groups. Third, the reported prevalence and incidence rates of diabetes were likely to be overestimated because the diagnosis of diabetes was not confirmed by a repeated measurement of fasting plasma glucose.
In addition, the article1 suffered from multiple errors in the organization of the references that led to significant confusion and sometimes difficulty in following the manuscript. In fact, several references mentioned in the text did not match . . . [Full Text of this Article]
AUTHOR INFORMATION
Nasser Mikhail, MD, MSc;
Dennis Cope, MD
RELATED ARTICLES
Antiretroviral Therapy and the Prevalence and Incidence of Diabetes—Reply
Todd T. Brown, Stephen R. Cole, and Xiuhong Li
Arch Intern Med. 2005;165(21):2537.
EXTRACT
| FULL TEXT
Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort Study
Todd T. Brown, Stephen R. Cole, Xiuhong Li, Lawrence A. Kingsley, Frank J. Palella, Sharon A. Riddler, Barbara R. Visscher, Joseph B. Margolick, and Adrian S. Dobs
Arch Intern Med. 2005;165(10):1179-1184.
ABSTRACT
| FULL TEXT
|
